Latest AI and machine learning research in bipolar disorder for healthcare professionals.
Despite increasingly widespread use of artificial intelligence-driven ambient scribes in medicine, the extent to which they may impact clinician practice is not well-studied. To characterize differences in documentation and treatment of psychiatric symptoms in primary care outpatient notes generated using ambient scribes. Case-control electronic health records Primary care annual visit notes from ...
Major depressive disorder (MDD) is a heterogeneous neuropsychiatric disorder with highly variable antidepressant outcomes. In randomized controlled trials (RCTs), low drug-placebo differences and high placebo response rates are persistent challenges. An objective biomarker that can prospectively identify which patients will respond to antidepressant or placebo could greatly enhance both clinical c...
Epilepsy is a neurological disorder that affects approximately 1% of the global population. The current method for seizure monitoring, seizure diaries...
Bipolar disorder is characterized by marked changes in mood and activity levels and is a leading cause of disability worldwide. We sought to investiga...
Steroid hormone profiles in affective disorders suggest hypothalamic– pituitary–adrenal (HPA) axis dysregulation and may reveal novel therapeutic targ...
Major depressive disorder (MDD) is a leading cause of disability worldwide, yet treatment response to antidepressants remains highly variable, with a ...
Artificial intelligence (AI) is increasingly leveraged in mental healthcare for early detection, monitoring, and personalized intervention. However, m...
There is a growing interest in performing automated, longitudinal tracking of sleep in the home environment using wearables and machine learning. Wear...
Weight gain is a common side effect in patients treated with olanzapine (N05AH03), contributing to increased risks of metabolic complications such as ...
Patients recently discharged from psychiatric hospitalization are at increased risk of intentional self-harm, including suicide. Using linked populati...
Clinical symptoms in serious mental illness (SMI) fluctuate dynamically, yet standard interview-based assessments often fail to capture these daily ch...
Conversational agents based on large language models (LLMs) have shown moderate efficacy in reducing depressive and anxiety symptoms. However, most ex...
Machine learning models have increasingly been used to identify predictors of treatment response in depression, and it is hoped that they may eventual...
A neurobiologically-based diagnosis with superior reliability in place of clinical interview-based diagnosis is a primary goal in psychiatry. Dynamic ...
Biomedical knowledge graphs (KGs), such as the Data Distillery Knowledge Graph (DDKG), capture known relationships among entities (e.g., genes, diseas...
Machine learning approaches pave a promising avenue to advance individual predictions about psychiatric illnesses, possibly using biomarkers. Here, we...
Low self-esteem (LoST) is a latent yet critical psychosocial risk factor that predisposes individuals to depressive disorders. Although structured too...
Despite the availability of more than 20 anti-seizure medications (ASMs), approximately half of patients with newly diagnosed epilepsy fail their firs...
Repetitive transcranial magnetic stimulation (rTMS) is an established intervention for treatment-resistant depression, but response rates remain highl...
Second-generation antipsychotics (SGAs) are frequently used off-label to manage behavioral symptoms in Alzheimer’s disease (AD), despite ongoing conce...